BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22287149)

  • 1. Prevalence and patterns of renal involvement in imaging of malignant lymphoproliferative diseases.
    Bach AG; Behrmann C; Holzhausen HJ; Katzer M; Arnold D; Spielmann RP; Surov A
    Acta Radiol; 2012 Apr; 53(3):343-8. PubMed ID: 22287149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and imaging of hepatic involvement in malignant lymphoproliferative disease.
    Bach AG; Behrmann C; Holzhausen HJ; Spielmann RP; Surov A
    Clin Imaging; 2012; 36(5):539-46. PubMed ID: 22920359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast enhanced magnetic resonance imaging of diffuse spinal bone marrow infiltration in patients with hematological malignancies.
    Zha Y; Li M; Yang J
    Korean J Radiol; 2010; 11(2):187-94. PubMed ID: 20191066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramuscular manifestation of non-Hodgkin lymphoma and myeloma: prevalence, clinical signs, and computed tomography features.
    Surov A; Holzhausen HJ; Arnold D; Schmidt J; Spielmann RP; Behrmann C
    Acta Radiol; 2010 Feb; 51(1):47-51. PubMed ID: 20088640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.
    Takehana CS; Twist CJ; Mosci C; Quon A; Mittra E; Iagaru A
    Nucl Med Commun; 2014 Mar; 35(3):276-81. PubMed ID: 24296883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging.
    Rahmouni A; Montazel JL; Divine M; Lepage E; Belhadj K; Gaulard P; Bouanane M; Golli M; Kobeiter H
    Radiology; 2003 Dec; 229(3):710-7. PubMed ID: 14593191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal affection in malignant lymphoma: imaging patterns in magnet resonance imaging].
    Beeskow AB; Schramm D; Bach AG; Surov A
    Rofo; 2018 Jul; 190(7):587-589. PubMed ID: 29695015
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal involvement in lymphoma: prevalence and various patterns of involvement on abdominal CT.
    El-Sharkawy MS; Siddiqui N; Aleem A; Diab AA
    Int Urol Nephrol; 2007; 39(3):929-33. PubMed ID: 17549602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of pseudocapsule of renal cell carcinoma with MR imaging and CT.
    Yamashita Y; Honda S; Nishiharu T; Urata J; Takahashi M
    AJR Am J Roentgenol; 1996 May; 166(5):1151-5. PubMed ID: 8615260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological features of Chinese patients with B-cell lymphoproliferative disorders and kidney infiltration.
    Cheung CY; Tang AHC; Wong YT; Chan GSW; Tang SCW
    Nephrology (Carlton); 2021 Aug; 26(8):650-658. PubMed ID: 33729651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoproliferative disorders in individuals with chronic hepatitis B and C in the Turkish population.
    Idilman R; Bozkus Y; Seval G; Mizrak D; Cinar K; Ustun Y; Bektas M; Arat M; Akbulut H; Doganay B; Ozden A
    J Med Virol; 2011 Jun; 83(6):974-80. PubMed ID: 21503909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
    Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
    Montanari F; O'Connor OA; Savage DG; Zain JM; Venkatraman S; McCormick EK; Crook MT; Tsao L; Sevilla DW; Bhagat G; Alobeid B
    Hum Pathol; 2010 Aug; 41(8):1150-8. PubMed ID: 20381113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal lymphoma: demonstration by MR imaging.
    Semelka RC; Kelekis NL; Burdeny DA; Mitchell DG; Brown JJ; Siegelman ES
    AJR Am J Roentgenol; 1996 Apr; 166(4):823-7. PubMed ID: 8610558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging.
    Hecht EM; Israel GM; Krinsky GA; Hahn WY; Kim DC; Belitskaya-Levy I; Lee VS
    Radiology; 2004 Aug; 232(2):373-8. PubMed ID: 15215544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orbital lymphoproliferative and inflammatory lesions.
    White V; Rootman J; Quenville N; Worth A; Robertson W
    Can J Ophthalmol; 1987 Dec; 22(7):362-73. PubMed ID: 3325158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population.
    Miller WT; Siegel SG; Montone KT
    Crit Rev Diagn Imaging; 1997 Dec; 38(6):569-85. PubMed ID: 9442979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance imaging of renal lymphoma with computed tomography correlation].
    Imai Y; Sone S; Serizawa S; Bae SH; Imai N; Hasegawa M; Yamashita K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Jul; 55(8):562-8. PubMed ID: 7638051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging features of posttransplantation lymphoproliferative disorder in pancreas transplant recipients.
    Meador TL; Krebs TL; Cheong JJ; Daly B; Keay S; Bartlett S
    AJR Am J Roentgenol; 2000 Jan; 174(1):121-4. PubMed ID: 10628466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of malignant and benign renal lesions using diffusion-weighted MRI with multiple b values.
    Erbay G; Koc Z; Karadeli E; Kuzgunbay B; Goren MR; Bal N
    Acta Radiol; 2012 Apr; 53(3):359-65. PubMed ID: 22334870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.